Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Clinically Isolated CNS Demyelinating Syndrome

1-anilino-8-naphthalenesulfonate has been researched along with Clinically Isolated CNS Demyelinating Syndrome in 2 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vesterhus, M1
Raeder, H1
Aurlien, H1
Gjesdal, CG1
Bredrup, C1
Holm, PI1
Molven, A1
Bindoff, L1
Berstad, A1
Njølstad, PR1
Hirsch, HE1

Other Studies

2 other studies available for 1-anilino-8-naphthalenesulfonate and Clinically Isolated CNS Demyelinating Syndrome

ArticleYear
Neurological features and enzyme therapy in patients with endocrine and exocrine pancreas dysfunction due to CEL mutations.
    Diabetes care, 2008, Volume: 31, Issue:9

    Topics: Demyelinating Diseases; Enzyme Therapy; Feces; Glycated Hemoglobin; Humans; Islets of Langerhans; Li

2008
Pathogenesis of demyelination in multiple sclerosis: contributions of microanalysis.
    Progress in clinical and biological research, 1980, Volume: 39

    Topics: Astrocytes; Body Water; Carboxypeptidase B; Carboxypeptidases; Demyelinating Diseases; DNA; Endopept

1980